CFC-CONTAINING ASTHMA MDIs COULD BE BANNED WHEN "THREE DISTINCT ALTERNATIVES" ARE AVAILABLE; ONE YEAR MARKETING OF NON-CFC ALTERNATIVES REQUIRED -- FDA

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet